Nanochon: $4.1 Million Seed Prime II Round Raised To Advance Knee Cartilage Implant Into First-in-Human Study
By Amit Chowdhry ● Today at 7:37 AM
Nanochon, a Washington, D.C.-based orthopedic device company developing an implant to treat articular cartilage defects in the knee, said it has secured commitments to close an oversubscribed $4.1 million Seed Prime II financing, bringing total capital raised to date to $11.3 million. The round was led by cultivate(MD), with participation from the University of Virginia UVA Seed Fund, WSGR, Wealthing VC Fund, and other investors. Nanochon said the majority of the financing came from existing backers, while also adding new individuals and funds to its investor base.